Last reviewed · How we verify
NCT07099573
Analysis of Hyperthermia as an Adjunctive Treatment to Evidence-based Clinical Intervention in Subjects With Bursitis: a Double-blind Randomized Clinical Trial
NA trial testing Hyperthermia in Bursitis in 120 participants. Not yet recruiting.
31 October 2025
Quick facts
| Lead sponsor | University of Malaga |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 120 |
| Start date | 1 August 2025 |
| Primary completion | 31 October 2025 |
| Estimated completion | 30 April 2026 |
Drugs / interventions tested
- Hyperthermia
- Physical Exercise
- Stretching
Conditions studied
- Bursitis — all drugs for Bursitis →
- Hyperthermia — all drugs for Hyperthermia →
Sponsor
University of Malaga
Who can join
Adults 18 to 60, any sex, with Bursitis or Hyperthermia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This project aims to analyze the use of hyperthermia within a bursitis treatment protocol, as well as to determine the difference between two and three sessions per week. Study participants will be divided into four intervention groups: the first will receive two sessions per week for a period of six months, while the second will receive three sessions per week for the same period. The treatment protocol will consist of therapeutic physical exercise focused on the affected joint, stretching of the involved muscles, and the application of hyperthermia to the bursa and surrounding areas. The third and fourth intervention groups will receive the same treatment as mentioned above, but without hyperthermia. The third group will receive three sessions per week, while the second group will receive two sessions per week. Two different types of measurement variables will be used: on the one hand, the objective variable will be measurement and assessment of the bursa using ultrasound imaging. Subjective measurement variables will also be used through validated questionnaires, which will address physical activity, perceived functional limitations, and the visual analog scale for pain perception.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07099573
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Hyperthermia
Trials testing the same drug.
- NCT06835049 — Feasibility of Total Neoadjuvant Treatment With HYPErthermia in Patients With High-risk Extremity and Trunk Soft Tissue · Phase 2 · recruiting
- NCT07372300 — Modulated Electro-Hyperthermia in Combination With Multimodal Therapy for Locally Advanced Rectal Cancer · Phase 3 · recruiting
- NCT07103226 — Analysis of Hyperthermia as an Adjunctive Treatment to Evidence-based Clinical Intervention in Subjects With Plantar Fas · NA · not yet recruiting
- NCT06831981 — Hyperthermia With Chemoradiotherapy in Rectal Cancer · NA · recruiting
- NCT06249750 — Clinical Application of Near-infrared Whole Body Heat Shock Multimodal Technique in Treatment of Castration-resistant Pr · Phase 2 · recruiting
Other University of Malaga trials
Trials by the same sponsor.
- NCT07472205 — Foot and Ankle Strengthening Program to Improve Physical Function in Menopausal Women · NA · not yet recruiting
- NCT07408622 — Virtual Reality Therapy for Wrist and Hand Injury Recovery · NA · not yet recruiting
- NCT07428304 — Cortical Changes After Upper Limb Immobilization Measured by Electroencephalography · not yet recruiting
- NCT07371715 — Home-Based Auricular Transcutaneous Vagus Nerve Stimulation (tVNS) for Sleep Quality and Psycho-Academic Outcomes in Hea · NA · not yet recruiting
- NCT06438666 — Effects Obtained at Manual Function After Applying Anodic Transcranial Direct Current Stimulation (tCDS) in Children Wit · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07099573 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Malaga
- Last refreshed: 1 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07099573.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing